Skip to Main Content (Press Enter)

Logo UNIBS
  • ×
  • Home
  • Persone
  • Strutture
  • Competenze
  • Pubblicazioni
  • Professioni
  • Corsi
  • Insegnamenti
  • Terza Missione

Competenze & Professionalità
Logo UNIBS

|

Competenze & Professionalità

unibs.it
  • ×
  • Home
  • Persone
  • Strutture
  • Competenze
  • Pubblicazioni
  • Professioni
  • Corsi
  • Insegnamenti
  • Terza Missione
  1. Pubblicazioni

Prescription Patterns in Descemet Membrane Endothelial Keratoplasty (DMEK): A European Survey

Articolo
Data di Pubblicazione:
2025
Abstract:
Purpose:To assess current prescription patterns in Descemet Membrane Endothelial Keratoplasty (DMEK) in Europe.Setting:Countries affiliated with the European Cornea and Cell Transplantation Registry (ECCTR) and the European Vision Institute Clinical Research Network (EVICR.net).Design:Cross-sectional study (European survey).Methods:An electronic survey was distributed to 16 national societies to gather data on prescription patterns for DMEK. Responses were categorized by three clinical goals: prevention of postoperative endophthalmitis, graft rejection, and pupillary block and glaucoma.Results:Responses from 136 surgeons revealed that medication protocols mainly came from departmental protocols (54%) or personal experiences (48%) rather than national guidelines (22%) (multiple answers were allowed). Infection prevention primarily relied on intraoperative (72%) and postoperative (92%) antibiotics, with preoperative use less common (18%). Steroids were the mainstay for rejection prevention, used intraoperatively (59%), postoperatively (100%), and occasionally preoperatively (13%). Steroids were typically tapered to once daily after six months (46%) and discontinued after varying durations (65%). Dexamethasone was the preferred steroid. For high-risk DMEK, the most common approach was adding another topical (30%) or systemic immunosuppressive drug (24%), such as cyclosporine or mycophenolate. For graft rejection, most respondents increased topical steroid frequency (85%) or added (peri)bulbar steroid injections (42%). Pupillary block and glaucoma prophylaxis mainly involved intraoperative mydriatics (34%); intraocular pressure-lowering agents were rarely used (0.7-2.2%). For steroid-induced ocular hypertension, the common approach was switching to a lower-potency steroid (40%) or reducing steroid frequency (43%).Conclusions:Current prescription patterns in routine and high-risk DMEK vary significantly, reflecting the lack of standardized guidelines.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Cornea; DMEK; Endothelial keratoplasty; Graft Rejection; Steroids
Elenco autori:
Ye, Y.; De Rooij, F.; Alejandre, N.; Van Den Biggelaar, F. J. H. M.; Bourcier, T.; Cochener-Lamard, B.; Figueiredo, F. C.; Galarreta, D. J.; Hjortdal, J.; Jones, G. L. A.; Nathan, N.; Nuijts, R. M. M. A.; Romano, V.; Rosa, A. M.; Seitz, B.; Tassignon, M. -J.; Wacker, K.; Dickman, M. M.
Autori di Ateneo:
ROMANO VITO
Link alla scheda completa:
https://iris.unibs.it/handle/11379/634279
Pubblicato in:
JOURNAL OF CATARACT AND REFRACTIVE SURGERY
Journal
  • Assistenza
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Designed by Cineca | 26.5.1.0